Greenberg Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$218K Buy
+8,749
New +$221K 0.09% 97
2025
Q2
$211K Buy
8,749
+600
+7% +$14K 0.08% 109
2025
Q1
$229K Buy
+8,149
New +$213K 0.09% 94

Other funds holding PFE

Greenberg Financial Group's PFE Position: Q4 2025 in Review

Greenberg Financial Group opened a new position in Pfizer (PFE) in Q4 2025: 8,749 shares worth $218K. The stake represents 0.09% of the portfolio and ranks #97 among its holdings. This is a return to the name: Greenberg Financial Group previously reported a position in PFE as recently as Q2 2025.

Greenberg Financial Group first reported a position in PFE in Q1 2025 and has held it in 3 quarters since. The position peaked at $229K in Q1 2025. 2,910 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Greenberg Financial Group held 8,749 shares of Pfizer worth $218K as of Q4 2025.
  • Pfizer was a new Greenberg Financial Group position in Q4 2025.
  • Pfizer made up 0.09% of Greenberg Financial Group's portfolio in Q4 2025, its #97 holding.
  • Greenberg Financial Group first reported a position in Pfizer in Q1 2025 and has held it in 3 quarters since.
  • Greenberg Financial Group's Pfizer position peaked at $229K in Q1 2025.
  • 2,910 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Greenberg Financial Group's 13F filing for Q4 2025, filed 22 Jan 2026.